A Phase 2, Prospective, Randomised, Open-Label Study Of Defibrotide For The Prevention Of Acute Graft-Versus-Host Disease (Agvhd) After Allogeneic Haematopoietic Cell Transplantation (Hct)
BONE MARROW TRANSPLANTATION（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要